A prospective pilot study in Italy found that gallium-68 PSMA-11 PET/MR and PET imaging can highlight blood vessels in liver cancer, extending the utility of a prostate cancer-targeted tracer into hepatocellular carcinoma imaging. Researchers at IRCCS Azienda Ospedaliero-Universitaria di Bologna reported that PSMA-11 PET illuminated vascular features in liver malignancy, offering an additional way to visualize disease biology beyond conventional imaging readouts. The study’s design and focus are notable because imaging of tumor vasculature can support treatment planning and response assessment, especially in settings where early prediction of disease behavior is difficult. For translational biotech, this represents a pragmatic cross-platform reuse of existing radiotracers to expand clinical indications, potentially accelerating evidence generation without starting from scratch on new chemistry and manufacturing pipelines.